Kayentis

Kayentis is a global provider of eCOA and Decentralized Clinical Trial solutions, aiming to simplify and streamline the collection of clinical trial data for pharmaceutical, biotech, and CROs. With a history dating back to 2003, the company specializes in eCOA solutions for phases I-IV across various therapeutic areas. Additionally, it has expanded its portfolio to support decentralized and hybrid trials, reflecting the evolving landscape of clinical research. Kayentis boasts an impressive track record, having conducted digital data collection for over 300 clinical trials in 90 countries, catering to 100,000 patients in 120 languages. The company operates from offices in the US (Boston), France (Grenoble), and Japan (Tokyo), employing 185 staff. Notably, its most recent milestone was a Debt Financing investment on 28 March 2023. Although the specific details of this investment are undisclosed, it indicates investor confidence in Kayentis' offerings and potential for growth within the pharmaceutical industry.